MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30273% above fair value
$4.13−0.03 (-0.72%)
Close on Nov 13, 2026Market cap $1.33BP/E –Yield –
MannKind operating margin
Operating margin is operating income as a percentage of revenue.
MannKind's operating margin for the twelve months ending Sep 30, 2026 was -2.9%. For fiscal 2025 it was 11.1%, against 25.4% the year before. The highest annual figure on record is 38.5% in fiscal 2016.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.1% | −14.3 |
| FY2024 | Dec 31, 2024 | 25.4% | +21.1 |
| FY2023 | Dec 31, 2023 | 4.4% | +68.6 |
| FY2022 | Dec 31, 2022 | -64.3% | −1.9 |
| FY2021 | Dec 31, 2021 | -62.3% | +11.2 |
| FY2020 | Dec 31, 2020 | -73.5% | −2.8 |
| FY2019 | Dec 31, 2019 | -70.7% | +204.2 |
| FY2018 | Dec 31, 2018 | -274.9% | +646.2 |
| FY2017 | Dec 31, 2017 | -921.1% | −959.6 |
| FY2016 | Dec 31, 2016 | 38.5% | +419924.2 |
| FY2012 | Dec 31, 2012 | -419885.7% | −138807.7 |
| FY2011 | Dec 31, 2011 | -281078.0% | −117101.7 |
| FY2010 | Dec 31, 2010 | -163976.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -2.1% | −25.2 |
| Q2 FY2026 | Jun 30, 2026 | -0.3% | −7.2 |
| Q1 FY2026 | Mar 31, 2026 | -1.8% | −30.3 |
| Q4 FY2025 | Dec 31, 2025 | -6.9% | −41.4 |
| Q3 FY2025 | Sep 30, 2025 | 23.0% | +4.8 |
| Q2 FY2025 | Jun 30, 2025 | 6.9% | −16.0 |
| Q1 FY2025 | Mar 31, 2025 | 28.5% | +3.2 |
| Q4 FY2024 | Dec 31, 2024 | 34.5% | +21.1 |
| Q3 FY2024 | Sep 30, 2024 | 18.2% | +8.3 |
| Q2 FY2024 | Jun 30, 2024 | 22.9% | +19.4 |
| Q1 FY2024 | Mar 31, 2024 | 25.2% | +40.0 |
| Q4 FY2023 | Dec 31, 2023 | 13.4% | +48.9 |
| Q3 FY2023 | Sep 30, 2023 | 9.9% | +39.2 |
| Q2 FY2023 | Jun 30, 2023 | 3.5% | +111.8 |
| Q1 FY2023 | Mar 31, 2023 | -14.8% | +162.5 |
| Q4 FY2022 | Dec 31, 2022 | -35.5% | +156.0 |
| Q3 FY2022 | Sep 30, 2022 | -29.3% | +0.4 |
| Q2 FY2022 | Jun 30, 2022 | -108.3% | −64.1 |
| Q1 FY2022 | Mar 31, 2022 | -177.3% | −141.7 |
| Q4 FY2021 | Dec 31, 2021 | -191.5% | −62.8 |
| Q3 FY2021 | Sep 30, 2021 | -29.7% | +29.8 |
| Q2 FY2021 | Jun 30, 2021 | -44.1% | +8.2 |
| Q1 FY2021 | Mar 31, 2021 | -35.5% | +8.4 |
| Q4 FY2020 | Dec 31, 2020 | -128.8% | −57.8 |
| Q3 FY2020 | Sep 30, 2020 | -59.5% | +0.7 |
| Q2 FY2020 | Jun 30, 2020 | -52.4% | +20.6 |
| Q1 FY2020 | Mar 31, 2020 | -43.9% | +33.6 |
| Q4 FY2019 | Dec 31, 2019 | -71.0% | −22.8 |
| Q3 FY2019 | Sep 30, 2019 | -60.2% | +421.9 |
| Q2 FY2019 | Jun 30, 2019 | -73.0% | +454.5 |
| Q1 FY2019 | Mar 31, 2019 | -77.5% | +695.7 |
| Q4 FY2018 | Dec 31, 2018 | -48.2% | +588.4 |
| Q3 FY2018 | Sep 30, 2018 | -482.1% | +897.2 |
| Q2 FY2018 | Jun 30, 2018 | -527.5% | +932.1 |
| Q1 FY2018 | Mar 31, 2018 | -773.1% | −121.7 |
| Q4 FY2017 | Dec 31, 2017 | -636.6% | −541.2 |
| Q3 FY2017 | Sep 30, 2017 | -1379.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -1459.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -651.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -95.4% | – |
See a number that looks wrong?